Literature DB >> 8772611

Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast.

S E Bulun1, G Sharda, J Rink, S Sharma, E R Simpson.   

Abstract

The fibroblast component of adipose tissue is the primary extraglandular site of aromatase P450 (P450arom) expression, which is responsible for the conversion of C19 steroids to estrogens. Previously, we have shown positive correlations between the level of P450arom transcripts and the ratio of fibroblasts to mature adipocytes in adipose tissue samples proximal to breast tumors. The present study was conducted to determine the distribution of P450arom messenger ribonucleic acid (RNA) levels and fibroblast to adipocyte ratios in disease-free breasts of premenopausal women. Adipose tissue samples were collected from 3 regions (outer, upper, and inner) of both breasts of 13 women undergoing reduction mammoplasty. The histological composition of adipose tissue (n = 12) was determined by morphometry using a computerized image analysis program. We used a competitive RT-PCR method employing rat P450arom complementary RNA as an internal standard to quantify adipose P450arom transcripts in tissue total RNA samples (n = 11). Overall, 67% of the highest fibroblast to adipocyte ratios and 64% of the highest P450arom transcript levels were detected in an outer breast region, whereas in only 1 patient were the highest values detected in an inner region. Parametric ANOVA showed significant differences between the fibroblast content of the regions [p(F) = 0.037]. This distribution pattern directly correlates with the most common or the least common sites of carcinoma in the breast, the outer and inner regions, respectively. Moreover, a direct relationship was demonstrated between adipose fibroblasts and P450arom transcripts within the breast, in that regions with the highest fibroblast to adipocyte ratios contained the highest P450arom transcript levels (by ANOVA of contrast variables, P = 0.0009). These results suggest that, similar to our previous findings in the breast bearing a tumor, adipose tissue aromatase expression in the disease-free breast is determined by the local ratio of fibroblasts to adipocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8772611     DOI: 10.1210/jcem.81.3.8772611

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  Mesenchymal stem cells in mammary adipose tissue stimulate progression of breast cancer resembling the basal-type.

Authors:  Min Zhao; Patrick C Sachs; Xu Wang; Catherine I Dumur; Michael O Idowu; Valentina Robila; Michael P Francis; Joy Ware; Matthew Beckman; Aylin Rizki; Shawn E Holt; Lynne W Elmore
Journal:  Cancer Biol Ther       Date:  2012-06-06       Impact factor: 4.742

Review 2.  Aromatase, breast cancer and obesity: a complex interaction.

Authors:  Serdar E Bulun; Dong Chen; Irene Moy; David C Brooks; Hong Zhao
Journal:  Trends Endocrinol Metab       Date:  2011-12-12       Impact factor: 12.015

3.  Aromatase immunoreactivity is increased in mammographically dense regions of the breast.

Authors:  Celine M Vachon; Hironobu Sasano; Karthik Ghosh; Kathleen R Brandt; David A Watson; Carol Reynolds; Wilma L Lingle; Paul E Goss; Rong Li; Sarah E Aiyar; Christopher G Scott; V Shane Pankratz; Richard J Santen; James N Ingle
Journal:  Breast Cancer Res Treat       Date:  2010-06-05       Impact factor: 4.872

Review 4.  Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells.

Authors:  Hei Jason Chan; Karineh Petrossian; Shiuan Chen
Journal:  J Steroid Biochem Mol Biol       Date:  2015-08-13       Impact factor: 4.292

5.  Prostaglandin E2 down-regulates sirtuin 1 (SIRT1), leading to elevated levels of aromatase, providing insights into the obesity-breast cancer connection.

Authors:  Kotha Subbaramaiah; Neil M Iyengar; Monica Morrow; Olivier Elemento; Xi Kathy Zhou; Andrew J Dannenberg
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

6.  Adiposity Results in Metabolic and Inflammation Differences in Premenopausal and Postmenopausal Women Consistent with the Difference in Breast Cancer Risk.

Authors:  H Zhao; J Wang; D Fang; O Lee; R T Chatterton; V Stearns; S A Khan; S E Bulun
Journal:  Horm Cancer       Date:  2018-03-15       Impact factor: 3.869

7.  Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy.

Authors:  Aruna V Krishnan; Srilatha Swami; Lihong Peng; Jining Wang; Jacqueline Moreno; David Feldman
Journal:  Endocrinology       Date:  2009-11-11       Impact factor: 4.736

8.  PPARγ agonists target aromatase via both PGE2 and BRCA1.

Authors:  Ofer Margalit; Dingzhi Wang; Raymond N Dubois
Journal:  Cancer Prev Res (Phila)       Date:  2012-10

9.  Simple tandem repeat (TTTA)n polymorphism in CYP19 (aromatase) gene and breast cancer risk in Nigerian women.

Authors:  Michael N Okobia; Clareann H Bunker; Joseph M Zmuda; Emmanuel R Ezeome; Stanley N C Anyanwu; Emmanuel E O Uche; Joseph Ojukwu; Lewis H Kuller; Robert E Ferrell
Journal:  J Carcinog       Date:  2006-05-09

10.  Role of adiponectin and its receptors in cancer.

Authors:  Stephanie Obeid; Lionel Hebbard
Journal:  Cancer Biol Med       Date:  2012-12       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.